Palmar plantar erythrodysesthesia history and symptoms: Difference between revisions

	Palmar plantar erythrodysesthesia Microchapters
Home
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Palmar plantar erythrodysesthesia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Palmar plantar erythrodysesthesia history and symptoms On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia history and symptoms All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Palmar plantar erythrodysesthesia history and symptoms
CDC on Palmar plantar erythrodysesthesia history and symptoms
Palmar plantar erythrodysesthesia history and symptoms in the news
Blogs on Palmar plantar erythrodysesthesia history and symptoms
Directions to Hospitals Treating Palmar plantar erythrodysesthesia
Risk calculators and risk factors for Palmar plantar erythrodysesthesia history and symptoms

VisualWikitext

Revision as of 15:22, 26 June 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The majority of patients with [disease name] are asymptomatic.

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

History and Symptoms

The majority of patients with [disease name] are asymptomatic.

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
Symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

History

Patients with [disease name]] may have a positive history of:

[History finding 1]
[History finding 2]
[History finding 3]

Common Symptoms

Common symptoms of [disease] include:

[Symptom 1]
[Symptom 2]
[Symptom 3]

Less Common Symptoms

Less common symptoms of [disease name] include

[Symptom 1]
[Symptom 2]
[Symptom 3]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Palmar plantar erythrodysesthesia}}
-{{CMG}}; '''Associate Editor(s)-in-Chief:''' Zain Fatiwala, M.D.
+{{CMG}}; {{AE}}
 ==Overview==
-Palmar plantar erthrodysesthesia usually presents in patients being treated with chemotherapeutic agents. The classic presentation is tingling and/or numbness of the palms and soles that evolve into painful, symmetric, and well0demarcated swelling and red plaques. Subsequently, the skin peels and resolution occurs. Painful red swelling of the hands and feet in a patient receiving chemotherapy is usually enough to make the diagnosis..
+The majority of patients with [disease name] are asymptomatic.
-==History and symptoms==
+OR
-The symptoms can occur anywhere between days to months after administration of the offending medication, depending on the dose and speed of administration (Baack and Burgdorf, 1991; Demirçay, 1997;). The patient first experiences tingling and/or numbness of the palms and soles that evolves into painful, symmetric, and well-demarcated swelling and red plaques. This is followed by peeling of the skin and resolution of the symptoms (Apisarnthanarax and Duvic 2003). Painful red swelling of the hands and feet in a patient receiving chemotherapy is usually characteristic presentation. At its maximum, the condition can lead to ulcers and erosions.<ref name="pmid17101468">{{cite journal| author=Janusch M, Fischer M, Marsch WCh, Holzhausen HJ, Kegel T, Helmbold P| title=The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy. | journal=Eur J Dermatol | year= 2006 | volume= 16 | issue= 5 | pages= 494-9 | pmid=17101468 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17101468  }}</ref>
-It is critical that differential be considered to prevent any adverse outcomes such as Graft versus host disease, Tinea manuum, and hand-foot skin reaction due to tyrosine kinase inhibitor.
+The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
+==History and Symptoms==
+*The majority of patients with [disease name] are asymptomatic.
+OR
+*The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
+*Symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
+===History===
+Patients with [disease name]] may have a positive history of:
+*[History finding 1]
+*[History finding 2]
+*[History finding 3]
+===Common Symptoms===
+Common symptoms of [disease] include:
+*[Symptom 1]
+*[Symptom 2]
+*[Symptom 3]
+===Less Common Symptoms===
+Less common symptoms of [disease name] include
+*[Symptom 1]
+*[Symptom 2]
+*[Symptom 3]
 ==References==
 {{reflist|2}}